The Impact of Artificial Intelligence on the Creation of Medicines

Estimated read time 1 min read

Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.

You May Also Like

More From Author

+ There are no comments

Add yours